Showing all 5 results

Daconib 45 mg Tablet

Molecule : DacomitinibManufacturer : Everest Pharma

Dacoplice 30 mg Tablet

Molecule : DacomitinibManufacturer : Pfizer
Dacoplice 30 mg Tablet contains dacomitinib, a targeted anticancer medicine classified as a tyrosine kinase inhibitor (TKI). It is used

LuciDac 15 mg Tablet

Molecule : DacomitinibManufacturer : Lucius Pharma

LuciDac 45 mg Tablet

Molecule : DacomitinibManufacturer : Lucius Pharma

Vizimpro 45 mg Tablet

Molecule : DacomitinibManufacturer : Pfizer
Vizimpro (dacomitinib) is a once‑daily, first‑generation, irreversible EGFR tyrosine kinase inhibitor used for adults with metastatic non‑small cell lung cancer